en · de · es · fr · pt
cardarine-notes.peptides6088.com › Topic › Regulatory Status And Detection Context — 2026 Update

Regulatory Status And Detection Context — 2026 Update

By Editorial Desk · published 2025-09-08 · last reviewed 2025-09-28 · Topic

A practical reference on Mass spectrometry: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.

This page was last updated on 2025-09-28 and is reviewed periodically as new material appears.

Regulatory Status and Detection Context

A persistent misconception is that cardarine is a fat-burning drug or a safe alternative to anabolic steroids. No approved therapeutic product exists, and human safety data are limited. The tumor findings in rodents remain a central concern in scientific reviews. Products sold online may contain inaccurate labels, impurities, or different compounds entirely, which complicates any assessment of effects. Independent testing of such products has reported frequent mislabeling. For these reasons, discussions in the literature emphasize risks and unknowns rather than benefits.

Cardarine is not approved for human therapeutic use in any major jurisdiction. It appears on the World Anti-Doping Agency Prohibited List as a PPARδ agonist within the hormone and metabolic modulators category. Sports organizations test for it because it has been detected in athlete samples and seized products. Regulatory actions against marketed research chemical versions have occurred in several countries, though enforcement varies. Availability through unregulated channels complicates oversight.

Identity and Regulatory Status

Clinical development stopped after rodent studies showed tumors at multiple sites. Whether those findings predict human cancer risk remains an open question, but they led sponsors to discontinue programs. Human safety data are limited to small, short-term studies that were not designed to assess cancer risk. Reported effects in those studies included changes in blood lipids, but the evidence is insufficient for medical use. Long-term consequences of nonmedical use are not well characterized. Questions about dose, duration, and individual susceptibility remain unresolved.

Cardarine is a common name for GW501516, an investigational compound developed in the 1990s for metabolic conditions. It acts as an agonist at peroxisome proliferator-activated receptor delta, a nuclear receptor involved in lipid and energy metabolism. The compound is frequently mislabeled as a selective androgen receptor modulator, or SARM, but its molecular target is different. GW501516 reached early clinical testing before development was discontinued. It has no approved therapeutic use in any country. The name cardarine is not a formal international nonproprietary name.

Regulatory treatment varies, but cardarine is not approved as a medicine. Sports authorities list GW501516 as a prohibited substance, and it is banned at all times under the World Anti-Doping Agency code. Many countries restrict sales for human consumption, while online vendors market it as a research chemical. Such products may lack purity data, and their actual contents can differ from the label. Purchasing or possessing cardarine may carry legal consequences depending on jurisdiction. The compound is not a dietary supplement ingredient in regulated markets.

Cardarine at a glance

PropertyValueNotes
Regulatory statusNot approved for human therapeutic useNo marketing authorization identified in major jurisdictions.
Anti-doping classPPARδ agonist; hormone and metabolic modulatorsListed on the WADA Prohibited List.
Common test matrixUrineAlso blood and tissue in research settings.
Typical analytical methodLC-MS/MSTargets parent compound and metabolites.
Major safety signalTumor findings in rodentsHuman relevance not established; limited human data.

Preclinical Findings and Safety Signals

Human trials of GW501516 were small and short in duration. They examined lipid levels, glucose handling, and other metabolic markers, but the programs were halted after the animal cancer findings. No approved therapeutic product exists, and published human data are insufficient for establishing long-term safety. Reports of use for athletic performance come mainly from non-clinical settings and cannot be verified through controlled trials. Independent testing of products sold as cardarine has found inconsistent purity and labeling.

Laboratory studies indicate that GW501516 activates PPARδ, a nuclear receptor involved in fatty acid oxidation and energy metabolism. In rodent experiments, treated animals often showed increased endurance and reduced fat mass. These effects were observed under controlled conditions and do not establish safe or effective use in humans. The exact dose-response relationship in humans remains poorly characterized. Species differences in metabolism can affect how results translate across animals and people.

Safety concerns emerged from long-term animal studies. In rodents given the compound for extended periods, researchers found an increased incidence of certain cancers, including liver and bladder tumors. These findings contributed to the discontinuation of clinical development. Whether similar risks apply to short-term or low-level exposure in humans is not established, and controlled human safety data are limited. The relevance of high-dose rodent carcinogenicity findings to human use remains a subject of debate.

Related pages on this site

Detection, Stability, and Quality

Quality assessment for cardarine samples usually combines identity, purity, and impurity testing. Nuclear magnetic resonance spectroscopy and mass spectrometry can confirm molecular structure, while high-performance liquid chromatography estimates purity. Certificates of analysis from testing laboratories may list these results, but they do not establish safety or legality. In the absence of approved manufacturing, products sold online may contain the wrong compound, variable amounts, or unlisted contaminants. Independent verification is therefore central to analytical work and to interpreting any reported biological activity.

Laboratory detection of GW501516 commonly uses liquid chromatography coupled with tandem mass spectrometry. The method can identify the parent compound or its metabolites in urine and blood after sample cleanup. Protein precipitation, solid-phase extraction, or enzymatic hydrolysis may precede analysis, depending on the matrix. Reference standards are required for accurate quantification and confirmation. Because the compound is not approved, testing often occurs in anti-doping, forensic, or research settings rather than routine clinical care. Results are reported with limits of detection and quantification.

Stability of GW501516 depends on form, temperature, light exposure, and moisture. Solid reference material is typically stored frozen or refrigerated in a desiccator and protected from light. Solutions in organic solvents such as dimethyl sulfoxide are often kept frozen in aliquots to reduce freeze-thaw cycling. Aqueous solubility is low, so aqueous stock solutions can be difficult to prepare without cosolvents. Degradation may appear as changes in chromatographic purity or mass spectral signal. Stability studies are needed to establish shelf life for any specific preparation.

Detection, Regulation, and Quality Context

Regulatory treatment of cardarine differs by context and jurisdiction. In competitive sport, the World Anti-Doping Agency lists PPARδ agonists, including GW501516, as prohibited at all times. Outside sport, it lacks approval as a prescription medicine in major drug markets, and products sold for human consumption may be treated as unapproved drugs. Some countries also restrict importation or sale through general consumer protection and medicines laws. These classifications affect availability, testing, and legal risk without establishing therapeutic value.

Because cardarine is not an approved medicine, no pharmacopeial monograph defines its identity, purity, or storage requirements. Laboratories typically rely on in-house methods and reference standards when testing materials labeled as GW501516. Certificates of analysis may report purity and identity for a specific batch, but their scope varies and they do not guarantee safety or legal status. Independent verification can include high-performance liquid chromatography, mass spectrometry, nuclear magnetic resonance, and elemental analysis. The distinction between research chemical labeling and human use is significant because quality standards and oversight differ.

Cardarine can be detected in biological samples and product materials using liquid chromatography coupled to tandem mass spectrometry (LC-MS/MS). The method separates compounds by chromatography and identifies them by mass-to-charge transitions, allowing low-level detection in urine or blood. Sample preparation often involves enzymatic hydrolysis, solid-phase extraction, or protein precipitation. Certified reference materials and isotope-labeled internal standards improve quantification. Detection windows depend on metabolism, matrix, and assay sensitivity, so no single universal window applies.

Further detail

== Background == During the Trump administration's second term, the US intensified its focus on drug cartels, characterizing the smugglers as terrorists. In August 2025, the US deployed warships and personnel to the Caribbean, citing the need to combat drug cartels. PBS News reported that Trump was using the military to counter cartels he blamed for trafficking fentanyl and other illicit drugs into the US and for fueling violence in American cities.

=== Availability === α-Bungarotoxin is available for purchase from multiple biotechnological companies, such as Sigma-Aldrich or Biotium. Researchers may purchase it from there to perform a variety of researches on the toxin. Regarding bioavailability, researchers performed a study in the spinal cord during embryonic development in the embryos of chicks. They found that that binding of α-bungarotoxin was specific and saturable within the concentration range of 1-34 mM. Meaning, as the concentration of α-bungarotoxin increased, the binding site became more and more limited. Reaching the maximum number at 34 mM. Once there was no binding sites available anymore, nicotine behaved in a competitive manner and pushed out the already-bound α-bungarotoxin. Another thing they found was that the dissociation constant (Kd) was 8.0 nM - a concentration of α-bungarotoxin where half of the binding site were occupied. Moreover, maximum binding capacity (Bmax) was found to be 106 +/- 12 fmol/mg - the maximum number of binding sites available per unit of protein. Finally, exogenously administered α-bungarotoxin showed to penetrate the spinal cord tissue and bind to its specific sites after 7 days.

Menthol is a monoterpenoid organic compound that occurs naturally in the oils of certain plants in the mint family, such as corn mint and peppermint. It is a white or clear waxy crystalline substance that is solid at room temperature and melts slightly above. The main form of menthol occurring in nature is (−)-menthol, which is assigned the (1R,2S,5R) configuration. For many people, menthol produces a cooling sensation when inhaled, eaten, or applied to the skin, and mint plants have been used for centuries for topical pain relief and as a food flavoring. Menthol has local anesthetic and counterirritant qualities, and it is widely used to relieve minor throat irritation. Menthol has been demonstrated to cause a subjective nasal decongestant effect without any objective decongestant action, and administration of menthol via a nasal inhaler in humans has also been shown to cause nasal decongestion.

=== Artificial synthesis === Prostacyclin can be synthesized from the methyl ester of prostaglandin F2α. After its synthesis, the drug is reconstituted in saline and glycerin. Because prostacyclin is so chemically labile, quantitation of their inactive metabolites, rather than the active compounds, is used to assess their rate of synthesis.

=== Policy === Since the mid-1980s pharmaceutical companies have invested in medications for cancer or chronic disease that have greater potential to make money and have "de-emphasized or dropped development of antibiotics". On 20 January 2016 at the World Economic Forum, "80 pharmaceutical and diagnostic companies" called for "transformational commercial models" at an international level to spur research and development on antibiotics and on the use of diagnostic tests. A number of countries are considering or implementing delinked payment models for new antimicrobials whereby payment is based on value rather than volume of drug sales. This offers the opportunity to pay for valuable new drugs even if they are reserved for use in relatively rare drug resistant infections.

Sources: en.wikipedia.org

Background from the literature

=== 1960s === The 1960s marked significant progress in immunology, molecular biology, and organ transplantation. In 1961, Marshall Nirenberg and Heinrich Matthaei deciphered the first codon of the genetic code, paving the way for understanding how cellular machinery translates genetic information into proteins. In 1967, South African surgeon Christiaan Barnard performed the first successful human-to-human heart transplant, demonstrating the feasibility of major organ replacement despite early challenges with tissue rejection.

==== Absorption ==== Tiagabine is nearly completely absorbed (>95%) and has an oral bioavailability of 90%. The time to peak levels is approximately 1 hour, with a range of 0.8 to 1.5 hours. Peak levels occur after 45 minutes in a fasted state and after 2.5 hours when taken with a high-fat meal. A high fat meal decreases peak levels by 40% but does not affect area-under-the-curve levels, indicating that it delays absorption but does not reduce the extent of absorption. Tiagabine was administered with food in clinical trials and it is recommended that it be taken with food. The pharmacokinetics of tiagabine are linear over a dose range of 2 to 24 mg. Steady-state levels are achieved after 2 days of continuous dosing and there is no accumulation with repeated administration. There have been found to be secondary peaks in circulating tiagabine levels which is suggestive of enterohepatic recycling.

Metenolone and its esters are banned from use in sports governed by the World Anti-Doping Agency. The NBA and NBPA also banned the use of metenolone and its esters under the Anti-Drug Program. There are known cases of doping in sports with metenolone esters by professional athletes.

Most taste buds on the tongue and other regions of the mouth can detect umami taste, irrespective of their location. (The tongue map in which different tastes are distributed in different regions of the tongue is a common misconception.) Biochemical studies have identified the taste receptors responsible for the sense of umami as modified forms of mGluR4, mGluR1, and taste receptor type 1 (TAS1R1 + TAS1R3), all of which have been found in all regions of the tongue bearing taste buds. These receptors are also found in some regions of the duodenum. A 2009 review corroborated the acceptance of these receptors, stating, "Recent molecular biological studies have now identified strong candidates for umami receptors, including the heterodimer TAS1R1/TAS1R3, and truncated type 1 and 4 metabotropic glutamate receptors missing most of the N-terminal extracellular domain (taste-mGluR4 and truncated-mGluR1) and brain-mGluR4." Receptors mGluR1 and mGluR4 are specific to glutamate whereas TAS1R1 and TAS1R3 are responsible for the synergism already described by Akira Kuninaka in 1957. However, as of this date, the specific role of each type of receptor in taste bud cells remained unclear. All three receptors work together to produce the taste sensation.

=== Regionalized menus === KFC adapts its menu internationally to suit regional tastes and there are over 300 KFC menu items worldwide. Some locations, such as the UK and the US, sell grilled chicken. In predominantly Islamic countries, the chicken served is halal. In Asia, there is a preference for spicy foods, such as the Zinger chicken burger. In many international markets, the seasoning used for the core chicken pieces product is available as a hot and spicy version as an alternative to the classic KFC recipe. The hot and spicy coating, as well as having a spicier flavour, also has a crispy consistency. In Bangladesh, India, Nepal and Sri Lanka, a grilled chicken known as "Smoky Red" is available. KFC locations in Taiwan, Hong Kong, Macau and Vietnam offer a roasted option known as Flava Crava. KFC's menu in China includes, among other items incorporating Chinese food items, rice bowls, noodle dishes, and chicken prepared in the style of Peking duck. Some locations in the US sell fried chicken livers and gizzards. A small number of US outlets offer an all-you-can-eat buffet option with a limited menu. Value menu items are sold under the "Streetwise" name in locations such as Canada, Nigeria, South Africa and Mauritius. Side dishes often include French fries, coleslaw, barbecue baked beans, corn on the cob, mashed potato, bread rolls and American biscuits. Salads include the bean salad, the Caesar salad and the garden salad. In a number of territories, KFC sells onion rings.

Sources: en.wikipedia.org

Further detail

== Examples == Receptors for which inverse agonists have been identified include the GABAA, melanocortin, mu opioid, histamine, serotonin, and beta adrenergic receptors. Both endogenous and exogenous inverse agonists have been identified, as have drugs at ligand gated ion channels and at G protein-coupled receptors.

This increase in system Xc- activity leads to an increase in extrasynaptic glutamate, causing stimulation of Group 2 mGluRs and an inhibition of synaptic release of glutamate. Cysteine prodrugs also lead to an increase in antioxidant properties by increasing levels of glutathione. Increased levels of glutathione lead to a lower toxicity of methamphetamine and alcohol, and cause a decrease in tumor formation after chronic smoking. N-acetylcysteine has been shown to decrease cravings and use of cocaine and tobacco, as well as other compulsive behaviors such as gambling and trichotillomania. Repeated administration of cocaine causes disruptions in glutamate homeostasis that lead to a decrease in function of EAATs. It is also possible that glutamate is diffusing from surrounding synapses and is stimulating extrasynaptic receptors. All of these factors may be leading to the disruptions in glutamate signaling that are associated with drug addiction.

Two years later the Madras and Bombay armies lost their posts of Commander-in-Chief. In 1895, the Presidency Armies were abolished and the Indian Army created thereby was grouped into four commands: Bengal, Madras (including Burma), Bombay (including Sind, Quetta, and Aden), and the Punjab (including the North-West Frontier and the Punjab Frontier Force). Each was under the command of a lieutenant general, who answered directly to the C-in-C, India. The Presidency armies were abolished with effect from 1 April 1895 by a notification of the Government of India through Army Department Order Number 981 dated 26 October 1894, unifying the three Presidency armies into a single Indian Army. The armies were amalgamated into four commands, Northern, Southern, Eastern, and Western. The Indian Army, like the Presidency armies, continued to provide armed support to the civil authorities, both in combating banditry and in case of riots and rebellion. One of the first external operations the new unified army faced was the 1899 to 1901 Boxer Rebellion in China. The 1st, 4th, and 14th Sikhs; 3rd Madras Native Infantry, 4th Goorkas, 22nd and 30th Bombay Native Infantry, 24th Punjab Infantry, 1st Madras Pioneers, No. 2 Company Bombay Sappers, No. 3 Company Madras Sappers, No. 4 Company Bengal Sappers, and the 1st Bengal Lancers, among other Indian units, all served during the Rebellion. Numerous Indian soldiers earned the China War Medal 1900 with the "Relief of Pekin" clasp for contributing to the relief of Peking and the International Legations from 10 June to 14 August 1900.

During oogenesis, cytoplasmic bridges called "ring canals" connect the forming oocyte to nurse cells. Nutrients and developmental control molecules move from the nurse cells into the oocyte. In the figure to the left, the forming oocyte can be seen to be covered by follicular support cells. After fertilization of the oocyte, the early embryo (or syncytial embryo) undergoes rapid DNA replication and 13 nuclear divisions until about 5000 to 6000 nuclei accumulate in the unseparated cytoplasm of the embryo. By the end of the eighth division, most nuclei have migrated to the surface, surrounding the yolk sac (leaving behind only a few nuclei, which will become the yolk nuclei). After the 10th division, the pole cells form at the posterior end of the embryo, segregating the germ line from the syncytium. Finally, after the 13th division, cell membranes slowly invaginate, dividing the syncytium into individual somatic cells. Once this process is completed, gastrulation starts. Nuclear division in the early Drosophila embryo happens so quickly, no proper checkpoints exist, so mistakes may be made in division of the DNA. To get around this problem, the nuclei that have made a mistake detach from their centrosomes and fall into the centre of the embryo (yolk sac), which will not form part of the fly. The gene network (transcriptional and protein interactions) governing the early development of the fruit fly embryo is one of the best understood gene networks to date, especially the patterning along the anteroposterior (AP) and dorsoventral (DV) axes (See under morphogenesis).

== Legal status == As of March 2022, the European Commission has taken new measures to control the psychoactive substance of 3-CMC. This decision is based on a risk assessment conducted by the EU Drugs Agency (EMCDDA) in November 2021. Since 3-CMC was prohibited in China (October 2015), it was found that most of the production was manufactured in India and little of the substance supply originates from inside Europe. Several European countries were ahead of the European Commission report by (generically) controlling the substance. Nowadays, in almost all countries 3-CMC is prohibited.

Sources: en.wikipedia.org

Frequently asked questions

Is cardarine approved for any medical use?

No. Cardarine has not received approval for human therapeutic use in major jurisdictions. It remains an investigational compound.

Why is cardarine prohibited in sport?

It is classified as a PPARδ agonist on the WADA Prohibited List. Anti-doping laboratories can detect it and its metabolites in urine. Its use is banned in competition and usually out of competition.

What is known about cardarine and cancer?

Rodent studies reported increased tumor incidence at multiple sites. The human relevance remains uncertain, but the findings contributed to discontinuation of development. No long-term human cancer data are available.

Is cardarine a SARM?

No. Cardarine is GW501516, a PPARδ agonist, while SARMs act on androgen receptors. The two classes are often grouped in informal discussions despite different mechanisms.

Network